Is CPHI (CPHI) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 127.3% / 30% | 22.2% / 30% | 10.0% / 30% | 0.15% / 5% | ✗ NOT HALAL |
| DJIM | 127.3% / 33% | 22.2% / 33% | 10.0% / 33% | 0.15% / 5% | ✗ NOT HALAL |
| MSCI | 24.1% / 33% | 4.2% / 33% | 1.9% / 33% | 0.15% / 5% | ✓ HALAL |
| S&P | 127.3% / 33% | 22.2% / 33% | 10.0% / 33% | 0.15% / 5% | ✗ NOT HALAL |
| FTSE | 24.1% / 33% | 4.2% / 33% | 1.9% / 50% | 0.15% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | -10.9% | |
| Operating Margin | -83.0% | |
| Net Margin | -78.7% | |
| Return on Equity (ROE) | -43.0% | |
| Return on Assets (ROA) | -13.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$466,362 |
| Free Cash Flow | -$758,080 |
| Total Debt | $4M |
| Debt-to-Equity | 42.9 |
| Current Ratio | 0.4 |
| Total Assets | $15M |
Price & Trading
| Last Close | $0.63 |
| 50-Day MA | $0.76 |
| 200-Day MA | $1.43 |
| Avg Volume | 47K |
| Beta | 1.2 |
|
52-Week Range
$0.50
| |
About CPHI (CPHI)
China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection for edema diseases, hypertension, acute renal failure, hyperkalemia, hypercalcemia, and acute drug poisoning; and Candesartan for hypertension. It offers Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and Pseudophedrine Hydrochlorida sustained release tablets. It offers Hepatocyte growth-promoting factors, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection for nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It supplies its products to hospitals and OTC pharmacies through provincial and municipal pharmaceutical logistics companies. The company is based in Haikou, the People's Republic of China.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is CPHI (CPHI) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), CPHI is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is CPHI's debt ratio?
CPHI's debt ratio is 127.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 24.1%.
What are CPHI's key financial metrics?
CPHI has a market capitalization of $3M, and revenue of $5M. The company maintains a gross margin of -10.9% and a net margin of -78.7%. Return on equity stands at -43.0%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.